Which Health-care Professional(s) to Talk About Advance Care Planning ?

Advance Care Planning Clinical Trial

— QPSPAS  

Official title:

Which Health-care Professional(s) to Talk About Advance Care Planning ? The Point of View of French Patients Followed in the Context of an Oncological Disease.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06376799
• Other study ID #: 38RC23.0437
• Secondary ID: 2024-A00485-42
• Status: Recruiting
• Start date: April 19, 2024
• Est. completion date: November 2, 2024

Study information

• Verified date: May 2024
• Source: University Hospital, Grenoble
• Contact: Jérémy Lascaux, Master
• Phone: 0630865262
• Email: lascaux.jeremy[@]hotmail.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this descriptive observational study is to evaluate the preference of French adult patients followed in the context of a oncological disease, regarding the choice of the preferred healthcare professional to discuss advance care planning.

To this end, voluntary participants will be asked to indicate their preferences by answering a self-questionnaire available in electronic or paper format.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 240
• Est. completion date: November 2, 2024
• Est. primary completion date: November 1, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria :

• Patients with neoplasic disease (under treatment, in exclusive palliative phase, under surveillance or in remission)

• French-speaking patients

Related Conditions & MeSH terms

• Advance Care Planning
• Patient Preference

Intervention

Other:
• Self-questionnaire
Provision of a self-questionnaire in digital or paper format for the patient. The patient will be asked to indicate their preferences regarding the primary and secondary objectives of the study.

Locations

Country	Name	City	State
France	CHU Grenoble Alpes	Grenoble

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Grenoble

Country where clinical trial is conducted

France, 

References & Publications (4)

Brinkman-Stoppelenburg A, Rietjens JA, van der Heide A. The effects of advance care planning on end-of-life care: a systematic review. Palliat Med. 2014 Sep;28(8):1000-25. doi: 10.1177/0269216314526272. Epub 2014 Mar 20. — View Citation

Kubi B, Istl AC, Lee KT, Conca-Cheng A, Johnston FM. Advance Care Planning in Cancer: Patient Preferences for Personnel and Timing. JCO Oncol Pract. 2020 Sep;16(9):e875-e883. doi: 10.1200/JOP.19.00367. Epub 2020 Apr 13. — View Citation

Peck V, Valiani S, Tanuseputro P, Mulpuru S, Kyeremanteng K, Fitzgibbon E, Forster A, Kobewka D. Advance care planning after hospital discharge: qualitative analysis of facilitators and barriers from patient interviews. BMC Palliat Care. 2018 Dec 5;17(1):127. doi: 10.1186/s12904-018-0379-0. — View Citation

Rietjens JAC, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M, van der Heide A, Heyland DK, Houttekier D, Janssen DJA, Orsi L, Payne S, Seymour J, Jox RJ, Korfage IJ; European Association for Palliative Care. Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol. 2017 Sep;18(9):e543-e551. doi: 10.1016/S1470-2045(17)30582-X. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Determining the healthcare professional preferred by cancer patients to talk about advance care planning	Hierarchical classification of healthcare professionals preferred by the patient via a self-questionnaire	Six months
Secondary	Determining cancer patients' second choice of healthcare professional to talk about advance care planning	Hierarchical classification of health professionals preferred as second choice via a self-questionnaire	Six months
Secondary	Evaluation of patient preferences regarding advance care planning, concerning the form, the moment it should be carried out, whether or not they wish to be accompanied by a relative, and the benefit of systematization	Percentage for each response to the questions relating to the modalities of carrying out the interview regarding advance care planning; the most relevant time to discuss advance care planning; the patient's wish to be accompanied or not by a relative at the time of this interview; and the patient's opinion on the relevance of systematically carrying out this interview.	Six months